Order Article Reprints

Eberle RJ, Gering I, Tusche M, Ostermann PN, Müller L, Adams O, Schaal H, Olivier DS, Amaral MS, Arni RK, et al. Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals. 2022; 15(5):540. https://doi.org/10.3390/ph15050540

Eberle, Raphael J., Ian Gering, Markus Tusche, Philipp N. Ostermann, Lisa Müller, Ortwin Adams, Heiner Schaal, Danilo S. Olivier, Marcos S. Amaral, Raghuvir K. Arni, and et al. 2022. "Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold" Pharmaceuticals 15, no. 5: 540. https://doi.org/10.3390/ph15050540

Eberle, R. J., Gering, I., Tusche, M., Ostermann, P. N., Müller, L., Adams, O., Schaal, H., Olivier, D. S., Amaral, M. S., Arni, R. K., Willbold, D., & Coronado, M. A. (2022). Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals, 15(5), 540. https://doi.org/10.3390/ph15050540